These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33540224)

  • 1. Acute effect of hydrocortisone for respiratory deterioration in preterm infants: Oxygenation, ventilation, vital signs, and electrolytes.
    Shimokaze T; Toyoshima K; Noguchi T; Aoki H; Saito T
    Early Hum Dev; 2021 Mar; 154():105320. PubMed ID: 33540224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
    JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiology and Predictors of Impaired Gas Exchange in Infants with Bronchopulmonary Dysplasia.
    Svedenkrans J; Stoecklin B; Jones JG; Doherty DA; Pillow JJ
    Am J Respir Crit Care Med; 2019 Aug; 200(4):471-480. PubMed ID: 30789787
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of postnatal hydrocortisone on cytokine profile in extremely preterm infants.
    Tamura K; Nagaoka M; Inomata S; Kawasaki Y; Makimoto M; Yoshida T
    Pediatr Int; 2022 Jan; 64(1):e15205. PubMed ID: 35831259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial.
    Onland W; Offringa M; Cools F; De Jaegere AP; Rademaker K; Blom H; Cavatorta E; Debeer A; Dijk PH; van Heijst AF; Kramer BW; Kroon AA; Mohns T; van Straaten HL; te Pas AB; Theyskens C; van Weissenbruch MM; van Kaam AH
    BMC Pediatr; 2011 Nov; 11():102. PubMed ID: 22070744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Analysis of Short-Term Respiratory Outcomes of Three Different Steroids Used in Clinical Practice in Intubated Preterm Infants.
    Nath S; Reynolds AM; Lakshminrusimha S; Ma C; Hudak ML; Ryan RM
    Am J Perinatol; 2020 Dec; 37(14):1425-1431. PubMed ID: 31382299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Marr BL; Mettelman BB; Bode MM; Gross SJ
    J Pediatr; 2019 Aug; 211():20-26.e1. PubMed ID: 31349916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postnatal oral hydrocortisone in treatment of bronchopulmonary dysplasia: an observational study.
    Mutlu B; Sandal G; Kanmaz G; Eraslan Z; Erdeve Ö; Oğuz ŞS; Dilmen U
    Tuberk Toraks; 2013; 61(3):245-9. PubMed ID: 24298974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan.
    Onland W; Merkus MP; Nuytemans DH; Jansen-van der Weide MC; Holman R; van Kaam AH;
    Trials; 2018 Mar; 19(1):178. PubMed ID: 29523175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
    Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
    Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2010 Jan; (1):CD001146. PubMed ID: 20091516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia.
    Banks BA; Seri I; Ischiropoulos H; Merrill J; Rychik J; Ballard RA
    Pediatrics; 1999 Mar; 103(3):610-8. PubMed ID: 10049965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronology and Determinants of Respiratory Function Changes Following Administration of Systemic Postnatal Corticosteroids in Extremely Preterm Infants.
    Dassios T; Kaltsogianni O; Hickey A; Bhat R; Greenough A
    J Pediatr; 2019 Dec; 215():17-23. PubMed ID: 31500862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation.
    Durand M; Mendoza ME; Tantivit P; Kugelman A; McEvoy C
    Pediatrics; 2002 Feb; 109(2):262-8. PubMed ID: 11826205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone therapy for bronchopulmonary dysplasia: improved respiratory mechanics without adrenal suppression.
    Brundage KL; Mohsini KG; Froese AB; Walker CR; Fisher JT
    Pediatr Pulmonol; 1992 Mar; 12(3):162-9. PubMed ID: 1641273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term dexamethasone therapy for bronchopulmonary dysplasia: acute effects and 1-year follow-up.
    Mammel MC; Fiterman C; Coleman M; Boros SJ
    Dev Pharmacol Ther; 1987; 10(1):1-11. PubMed ID: 3582071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.